SCHEMBL21090063

SCHEMBL21090063

NC12CCCCCCCCC1C2

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24725969 1.00
SCHEMBL20878262 1.00 KDM4E (0.32) KDM4EMAPT
SCHEMBL20878295 1.00 KDM4E (0.32) KDM4EMAPT
SCHEMBL19645440 1.00 KDM4E (0.32) KDM4EMAPT
SCHEMBL18808899 1.00
SCHEMBL19250369 0.97
SCHEMBL12231800 0.89
SCHEMBL22216236 0.89
Hydrochloric Acid SCHEMBL30259297 0.86
SCHEMBL8777072 0.83 KDM4E (0.34) KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141044-A1 PHARMACEUTICAL FORMULATIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND LIVER DISORDERS VIKING THERAPEUTICS, INC. (US) 2023-07-27 WO disclosed
WO-2019110663-A1 1,2,4-OXADIAZOLE DERIVATIVES AS HISTONE DEACETYLASE 6 INHIBITORS ORYZON GENOMICS, S.A. (ES) 2019-06-13 WO disclosed